SCICLONE PHARMACEUTICALS INC (SCLN) Stock Price & Overview
NASDAQ:SCLN • US80862K1043
Current stock price
The current stock price of SCLN is 11.15 null. Today SCLN is down by 0%. In the past month the price increased by 0.45%. In the past year, price increased by 11.39%.
SCLN Key Statistics
- Market Cap
- 581.919M
- P/E
- 13.64
- Fwd P/E
- N/A
- EPS (TTM)
- 0.82
- Dividend Yield
- N/A
SCLN Stock Performance
SCLN Stock Chart
SCLN Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to SCLN. When comparing the yearly performance of all stocks, SCLN turns out to be only a medium performer in the overall market: it outperformed 64.39% of all stocks.
SCLN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SCLN. SCLN has an excellent financial health rating, but there are some minor concerns on its profitability.
SCLN Earnings
SCLN Forecast & Estimates
SCLN Financial Highlights
Over the last trailing twelve months SCLN reported a non-GAAP Earnings per Share(EPS) of 0.8174. The EPS increased by 9.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 25.18% | ||
| ROA | 15.6% | ||
| ROE | 17.34% | ||
| Debt/Equity | 0 |
SCLN Ownership
About SCLN
Company Profile
Sciclone Pharmaceuticals, Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. They have focused their current product development and commercial activities on the following diseases: hepatitis C, hepatocellular carcinoma, malignant melanoma, hepatitis B, HIV, drug-resistant tuberculosis, cystic fibrosis and others.
Company Info
SCICLONE PHARMACEUTICALS INC
950 TOWER LANE SUITE 900
FOSTER CITY CA 94404
CEO: Friedhelm Blobel
Phone: 650-358-3456
SCICLONE PHARMACEUTICALS INC / SCLN FAQ
What does SCICLONE PHARMACEUTICALS INC do?
Sciclone Pharmaceuticals, Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. They have focused their current product development and commercial activities on the following diseases: hepatitis C, hepatocellular carcinoma, malignant melanoma, hepatitis B, HIV, drug-resistant tuberculosis, cystic fibrosis and others.
What is the stock price of SCICLONE PHARMACEUTICALS INC today?
The current stock price of SCLN is 11.15 null.
Does SCICLONE PHARMACEUTICALS INC pay dividends?
SCLN does not pay a dividend.
How is the ChartMill rating for SCICLONE PHARMACEUTICALS INC?
SCLN has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Who owns SCICLONE PHARMACEUTICALS INC?
You can find the ownership structure of SCICLONE PHARMACEUTICALS INC (SCLN) on the Ownership tab.